UK markets closed
NIKKEI 225
38,703.51 +213.34 (+0.55%) HANG SENG
18,476.80 +51.84 (+0.28%) CRUDE OIL
75.67 +1.60 (+2.16%) GOLD FUTURES
2,394.50 +19.00 (+0.80%) DOW
38,836.11 +28.78 (+0.07%) Bitcoin GBP
55,581.69 -234.30 (-0.42%)
BMY Sep 2024 57.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:47PM EDT. Market open.
| Previous close | 16.65 |
| Open | 16.65 |
| Bid | 16.55 |
| Ask | 16.90 |
| Strike | 57.50 |
| Expiry date | 2024-09-20 |
| Day's range | 16.65 - 16.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 457 |
Insider MonkeyHere’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
We recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE:BMY) ranks 2nd in the list. Click to see the full list of 11 stocks Cramer is bearish on. In this article we will take a deeper look at BMY and find out whether Cramer’s thesis holds any weight. […]
ZacksBristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
- Zacks
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
© 2024 Yahoo. All rights reserved.